In view of our data and on the fact that the intended use of several therapeutic strategy is to cause an increase of ROS (e.g. radiation therapy), we speculate that inhibiting NRF2 would remove an important survival mechanism in cancer cells. The gene discussed is NFE2L2; the disease is cancer.